Reuters Reported FDA Said Looking For Temporary Suppliers Of Cancer Drug Methotrexate To Ease Shortages
Portfolio Pulse from Charles Gross
The FDA is seeking temporary suppliers of the cancer drug Methotrexate to address shortages. Pfizer (PFE) and Teva (TEVA) may be mentioned in the article.
June 09, 2023 | 5:41 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Pfizer may be mentioned in the article about FDA seeking temporary suppliers for Methotrexate.
The article mentions Pfizer (PFE) as a possible supplier for Methotrexate. However, it is not clear if they will be chosen or if they will benefit from this situation. Therefore, the short-term impact on their stock price is neutral.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
Teva may be mentioned in the article about FDA seeking temporary suppliers for Methotrexate.
The article mentions Teva (TEVA) as a possible supplier for Methotrexate. However, it is not clear if they will be chosen or if they will benefit from this situation. Therefore, the short-term impact on their stock price is neutral.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50